KR101165891B1 - Method of preparing ß-sustituted chiral g-lactol,g-lactone and 3-substituted chiral tetrahydrofurane and chiral g-lactol, g-lactone and chiral tetrahydrofurane prepared by thereof - Google Patents

Method of preparing ß-sustituted chiral g-lactol,g-lactone and 3-substituted chiral tetrahydrofurane and chiral g-lactol, g-lactone and chiral tetrahydrofurane prepared by thereof Download PDF

Info

Publication number
KR101165891B1
KR101165891B1 KR1020100000243A KR20100000243A KR101165891B1 KR 101165891 B1 KR101165891 B1 KR 101165891B1 KR 1020100000243 A KR1020100000243 A KR 1020100000243A KR 20100000243 A KR20100000243 A KR 20100000243A KR 101165891 B1 KR101165891 B1 KR 101165891B1
Authority
KR
South Korea
Prior art keywords
gamma
substituted
lactol
optically active
formula
Prior art date
Application number
KR1020100000243A
Other languages
Korean (ko)
Other versions
KR20110080077A (en
Inventor
김성곤
Original Assignee
경기대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 경기대학교 산학협력단 filed Critical 경기대학교 산학협력단
Priority to KR1020100000243A priority Critical patent/KR101165891B1/en
Publication of KR20110080077A publication Critical patent/KR20110080077A/en
Application granted granted Critical
Publication of KR101165891B1 publication Critical patent/KR101165891B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/36Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/06Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D307/08Preparation of tetrahydrofuran
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

본 발명은 베타위치가 치환된 광학활성의 감마-락톨, 감마-락톤 및 3번 위치가 치환된 광학활성의 테트라히드로퓨란의 제조 방법 및 이에 의해 제조된 광확활성의 감마-락톨, 감마-락톤 및 테트라히드로퓨란에 관한 것으로, 상기 베타위치가 치환된 광학활성의 감마-락톨의 제조 방법은 인돌, 피롤 또는 아민기가 치환된 벤젠을 감마-히드록시 알파, 베타-불포화 알데히드에 키랄 아민 촉매의 존재하에 1,4-첨가반응시키는 촉매반응 단계를 포함한다.
상기 방법은 종래보다 공정이 단순하여 손쉽게 많은 물질의 합성에 중간체로 이용되는 베타위치가 치환된 광학활성의 감마-락톤과 3번 위치가 치환된 광학활성의 테트라히드로퓨란을 높은 수율로 얻을 수 있다. 또한, 중금속 촉매를 사용하지 않고 유기화합물 자체를 촉매로 사용하여 공정이 용이하고 별도의 중금속 촉매 제거 공정이 필요치 않다.
The present invention relates to a method for preparing optically active gamma-lactol, gamma-lactone and beta-substituted optically active tetrahydrofuran, and the light-producing gamma-lactol, gamma-lactone and A method for preparing an optically active gamma-lactol in which the beta-position is substituted is tetrahydrofuran. In the presence of a chiral amine catalyst in a gamma-hydroxy alpha, beta-unsaturated aldehyde, a benzene substituted with indole, pyrrole or amine group A 1,4-addition catalysis step is included.
Since the process is simpler than the conventional method, the beta-substituted optically active gamma-lactone and tertiary-substituted optically active tetrahydrofuran can be obtained in high yield easily used as intermediates for the synthesis of many materials. . In addition, since the organic compound itself is used as a catalyst without using a heavy metal catalyst, the process is easy and a separate heavy metal catalyst removal process is not required.

Description

베타위치가 치환된 광학활성의 감마-락톨, 감마-락톤 및 3번 위치가 치환된 광학활성의 테트라히드로퓨란의 제조 방법 및 이에 의해 제조된 광학활성의 감마-락톨, 감마-락톤 및 테트라히드로퓨란 {Method of preparing β-sustituted chiral γ-lactol,γ-lactone and 3-substituted chiral tetrahydrofurane and chiral γ-lactol, γ-lactone and chiral tetrahydrofurane prepared by thereof}Method for preparing optically active gamma-lactol, gamma-lactone and beta-substituted optically active tetrahydrofuran, and the optically active gamma-lactol, gamma-lactone and tetrahydrofuran {Method of preparing β-sustituted chiral γ-lactol, γ-lactone and 3-substituted chiral tetrahydrofurane and chiral γ-lactol, γ-lactone and chiral tetrahydrofurane prepared by conjugate}

본 발명은 베타위치가 치환된 광학활성의 감마-락톨, 감마-락톤 및 3번 위치가 치환된 광학활성의 테트라히드로퓨란의 제조 방법 및 이에 의해 제조된 광학활성의 감마-락톨, 감마-락톤 및 테트라히드로퓨란에 관한 것으로, 구체적으로는 중금속 촉매를 사용하지 않아 공정이 간단하고, 거울상 선택성이 높은 베타위치가 치환된 광학활성의 감마-락톨, 감마-락톤 및 3번 위치가 치환된 광학활성의 테트라히드로퓨란을 높은 수율로 얻을 수 있는 제조 방법 및 이에 의해 제조된 광학활성의 감마-락톨, 감마-락톤 및 테트라히드로퓨란에 관한 것이다.
The present invention provides a method for preparing optically active gamma-lactol, gamma-lactone and beta-substituted optically active tetrahydrofuran, and the optically active gamma-lactol, gamma-lactone and The present invention relates to tetrahydrofuran, and specifically, does not use a heavy metal catalyst, and thus, the process is simple, and the optically active gamma-lactol, gamma-lactone, and 3-position-substituted optical activity having a high enantioselectivity are substituted. The present invention relates to a process for obtaining tetrahydrofuran in high yield and to an optically active gamma-lactol, gamma-lactone and tetrahydrofuran produced thereby.

광학활성의 감마-락톤은 다양한 용도의 키랄 화합물의 제조에 이용되는 유용한 키랄 중간체이다. 거울상 선택적으로 순수한 감마-락톤은 약리활성을 나타내는 여러 천연물에 분포하고 있고, 이러한 천연물을 합성하는 데 중요한 역할을 담당하고 있다. 농약, 의약의 중간체, 고분자 용제 및 중합촉매등으로 사용되어지며, 감마-락탐 및 감마-아미노 알코올의 합성에 전구체로 유용하다. Optically active gamma-lactones are useful chiral intermediates used in the preparation of chiral compounds for various applications. Enantioselectively pure gamma-lactone is distributed in several natural products that exhibit pharmacological activity and plays an important role in synthesizing these natural products. It is used as agrochemicals, pharmaceutical intermediates, polymer solvents and polymerization catalysts, and is useful as a precursor for the synthesis of gamma-lactams and gamma-amino alcohols.

이러한 감마-락톤의 중요성 때문에 보다 쉽고 효과적으로 합성하려는 노력들이 진행되고 있다. 현재까지 개발된 광학활성의 감마-락톤의 제조 방법은 크게 세 가지 형태로 나눌 수 있다. 첫 째로 라세믹 감마-락톤 화합물을 효소를 이용해 분리하는 방법이 있다 (참조문헌: (a) Forzato, C.; Gandolfi, R.; Molinari, F.; Nitti, P.; Pitacco, G.; Valentin, E. Tetrahedron : Asymmetry 2001, 12, 1039. (b) Brenna, E.; Negri, D. C.; Fuganti, C.; Serra, S. Tetrahedron : Asymmetry 2001, 12, 1871.). 그러나 이 방법에서는 실제 원하는 감마-락톤 화합물을 최대 50% 까지만 얻을 수 있기 때문에 효율성 면에서 떨어진다. 두 번째는 키랄 보조기를 이용해 광학활성의 감마-락톤을 합성하는 방법이다 (참고문헌: (a) Koch, S. S. C.; Chamberlin, A. R. J. Org . Chem . 1993, 58, 2725. (b) de L. Vanderiei, J. M.; Coelho, F.; Almeida, W. P. Synth . Commun . 1998, 28, 3047.) 이 방법에서는 광학활성의 감마-락톤 화합물을 얻기 위해 적절한 키랄한 물질을 보조기로 사용하여야 한다. 이러한 키랄 보조기는 회수하여 재사용이 가능하다고 하나, 실제로는 재사용되는 경우가 극히 드물므로 비용 소모가 많다. 세 번째 방법은 현재 가장 많이 연구된 방법으로 키랄 환경을 가지는 금속 촉매를 이용하여 감마-락톤을 합성하는 방법이다. 상기 세 번째 방법은 작은 촉매량을 사용해 높은 거울상 선택성을 가지는 광학활성의 감마-락톤을 만들수 있는 특징을 가지지만, 로듐(Rh), 코발트(Co) 등과 같은 중금속을 촉매로 사용하고 있다. 이러한 중금속들은 높은 촉매 효과를 보이기는 하지만, 가격적으로 비쌀 뿐만 아니라, 합성된 화합물을 이용해 의약을 개발할 경우, 잔류하는 중금속을 필히 제거해야 하는 단점을 가지고 있다. Due to the importance of gamma-lactones, efforts are being made to synthesize more easily and effectively. The production method of the optically active gamma-lactone developed to date can be divided into three types. First, there is a method for separating racemic gamma-lactone compounds using enzymes (see (a) Forzato, C .; Gandolfi, R .; Molinari, F .; Nitti, P .; Pitacco, G .; Valentin , E. Tetrahedron : Asymmetry 2001 , 12 , 1039. (b) Brenna, E .; Negri, DC; Fuganti, C .; Serra, S. Tetrahedron : Asymmetry 2001 , 12 , 1871.). However, this method is less efficient because only up to 50% of the desired gamma-lactone compound can be obtained. The second is a method of synthesizing optically active gamma-lactones using chiral auxiliaries (see: (a) Koch, SSC; Chamberlin, AR J. Org . Chem . 1993 , 58 , 2725. (b) de L. Vanderiei, JM; Coelho, F .; Almeida, WP Synth . Commun . 1998 , 28 , 3047.) In this method, suitable chiral materials should be used as auxiliary to obtain optically active gamma-lactone compounds. Such chiral braces are said to be recoverable and reusable, but they are very costly because they are rarely reused in practice. The third method is currently the most studied method of synthesizing gamma-lactone using a metal catalyst having a chiral environment. The third method has the characteristic of making an optically active gamma-lactone having high enantioselectivity using a small amount of catalyst, but using heavy metals such as rhodium (Rh) and cobalt (Co) as catalysts. Although these heavy metals show a high catalytic effect, they are expensive and have the disadvantage of removing residual heavy metals when developing medicines using synthesized compounds.

3번 위치가 치환된 광학활성의 테트라히드로퓨란 또한 약리활성을 나타내는 여러 가지 중요한 천연물에 분포하고 있고, 이러한 천연물을 합성하는 데 중요한 역할을 담당하고 있다. 그러나, 3번 위치가 치환된 광학활성의 테트라히드로퓨란의 거울상 선택적인 합성은 구조적인 요인으로 인해 쉽지가 않다. 현재 이 3번 위치가 치환된 광학활성의 테트라히드로퓨란의 합성 방법으로는 키랄 환경을 가지는 금속 촉매를 이용한 방법만이 알려져 있다 (참고문헌: Loy, R. N.; Jacobsen, E. N. J. Am. Chem . Soc. 2009, 131, 2786). 이 방법에서도 다양한 치환기의 도입이 가능한 것이 아니라 메틸알코올기가 도입된 경우에 한정되고 있다.
Optically active tetrahydrofuran substituted at position 3 is also distributed in various important natural products exhibiting pharmacological activity, and plays an important role in synthesizing such natural products. However, enantioselective synthesis of optically active tetrahydrofuran substituted at position 3 is not easy due to structural factors. Currently, only a method using a metal catalyst having a chiral environment is known as a method for synthesizing an optically active tetrahydrofuran substituted at the 3 position (Ref. Loy, RN; Jacobsen, EN J. Am. Chem . Soc 2009 , 131 , 2786). In this method, various substituents cannot be introduced, but are limited to the case where a methyl alcohol group is introduced.

상기의 문제점을 해결하기 위하여 본 발명의 목적은 중금속 촉매를 사용하지 않아 공정이 간단하고, 거울상 선택성이 높은 베타위치가 치환된 광학활성의 감마-락톨, 감마-락톤 및 3번 위치가 치환된 광학활성의 테트라히드로퓨란을 높은 수율로 얻을 수 있는 제조 방법 및 이에 의해 제조된 광학활성의 감마-락톨, 감마-락톤 및 테트라히드로퓨란을 제공하는데 있다.
In order to solve the above problems, an object of the present invention is not to use a heavy metal catalyst, the process is simple, and the beta-substituted optically active gamma-lactol, gamma-lactone, and 3-position-substituted optical having high enantioselectivity The present invention provides a method for producing an active tetrahydrofuran in high yield and an optically active gamma-lactol, gamma-lactone, and tetrahydrofuran.

상기의 목적을 달성하고자 본 발명은,The present invention to achieve the above object,

인돌, 피롤 또는 아민기가 치환된 벤젠을 감마-히드록시 알파, 베타-불포화 알데히드(γ-hydroxyα,β-unsaturated aldehyde)에 키랄 아민 촉매의 존재하에 1,4-첨가 반응시키는 촉매반응 단계를 포함하는 베타 위치가 치환된 광학활성의 감마-락톨의 제조 방법을 제공한다.
A catalytic reaction step of reacting benzene substituted with an indole, pyrrole or amine group with gamma-hydroxy alpha, beta-unsaturated aldehyde (γ-hydroxyα, β-unsaturated aldehyde) in the presence of a chiral amine catalyst. Provided is a method for preparing optically active gamma-lactol with a beta position substituted.

상기 인돌은 하기 화학식 1 로 표현될 수 있다:The indole may be represented by the following Chemical Formula 1:

[화학식 1][Formula 1]

Figure 112010000234329-pat00001
Figure 112010000234329-pat00001

(상기 화학식 1 에서,(In Chemical Formula 1,

R1 은 탄소수 1 내지 14 의 치환 또는 비치환된 알킬기, 아릴기 또는 알릴기이며,R 1 Is a substituted or unsubstituted alkyl, aryl or allyl group having 1 to 14 carbon atoms,

R2 는 수소, 탄소수 1 내지 14 의 알킬기, 알콕시기 또는 할로젠기이다.)
R 2 Is hydrogen, an alkyl group having 1 to 14 carbon atoms, an alkoxy group or a halogen group.)

상기 피롤은 하기 화학식 2 로 표현될 수 있다:The pyrrole may be represented by the following Chemical Formula 2:

[화학식 2][Formula 2]

Figure 112010000234329-pat00002
Figure 112010000234329-pat00002

(상기 화학식 2 에서,(In Chemical Formula 2,

R3 은 탄소수 1 내지 14 의 치환 또는 비치환된 알킬기, 알릴기 또는 아릴기이다)
R 3 Is a substituted or unsubstituted alkyl, allyl or aryl group having 1 to 14 carbon atoms)

상기 아민기가 치환된 벤젠은 하기 화학식 3 으로 표현될 수 있다:Benzene substituted with the amine group may be represented by the following Formula 3:

[화학식 3](3)

Figure 112010000234329-pat00003
Figure 112010000234329-pat00003

(상기 화학식 3 에서,(In Chemical Formula 3,

R4 은 탄소수 1 내지 10 의 디알킬아민이고, R 4 Is dialkylamine having 1 to 10 carbon atoms,

R5 은 수소 또는 탄소수 1 내지 10 의 알킬 알콕시기이다.)
R 5 Is hydrogen or an alkyl alkoxy group having 1 to 10 carbon atoms.)

상기 감마-히드록시 알파, 베타-불포화 알데히드는 하기 화학식 4 로 표현될 수 있다:The gamma-hydroxy alpha, beta-unsaturated aldehyde may be represented by the following formula (4):

[화학식 4][Formula 4]

Figure 112010000234329-pat00004

Figure 112010000234329-pat00004

상기 키랄 아민 촉매는 하기 화학식 5 또는 6 으로 표현되는 화합물 또는 이들의 혼합물일 수 있다:The chiral amine catalyst may be a compound represented by Formula 5 or 6 or a mixture thereof:

[화학식 5][Chemical Formula 5]

Figure 112010000234329-pat00005
Figure 112010000234329-pat00005

[화학식 6][Formula 6]

Figure 112010000234329-pat00006

Figure 112010000234329-pat00006

상기 촉매 반응은 -40 내지 -10 ℃에서 2 내지 50 시간 동안 유기용매에서 진행될 수 있다.
The catalytic reaction may be carried out in an organic solvent for 2 to 50 hours at -40 to -10 ℃.

상기 유기용매는 메틸렌클로라이드, 벤젠, 디에틸에테르, 아세톤, 아세토니트릴, 톨루엔, 테트라히드로푸란, 메탄올 및 이소프로판올로 이루어진 군으로부터 선택된 단독 또는 이들의 혼합물일 수 있다.
The organic solvent may be a single or a mixture thereof selected from the group consisting of methylene chloride, benzene, diethyl ether, acetone, acetonitrile, toluene, tetrahydrofuran, methanol and isopropanol.

상기 촉매 반응에서 인돌, 피롤 또는 아민기가 치환된 벤젠과 감마-히드록시 알파, 베타 불포화 알데히드는 1:1 내지 1:3 의 몰비로 반응시킬 수 있다.
In the catalytic reaction, benzene substituted with indole, pyrrole or amine group and gamma-hydroxy alpha, beta unsaturated aldehyde may be reacted in a molar ratio of 1: 1 to 1: 3.

상기 키랄 아민 촉매는 인돌, 피롤 또는 아민기가 치환된 벤젠에 대하여 5 내지 20 몰% 로 첨가될 수 있다.
The chiral amine catalyst may be added in an amount of 5 to 20 mol% with respect to benzene substituted with indole, pyrrole or amine group.

본 발명의 다른 목적을 달성하고자 본 발명은,The present invention to achieve another object of the present invention,

상기 방법에 의해 제조된 감마-락톨을 산화시키는 산화반응 단계를 포함하는 베타위치가 치환된 광학활성의 감마-락톤의 제조 방법을 제공한다.It provides a method for producing a beta-substituted optically active gamma-lactone comprising an oxidation step of oxidizing gamma-lactol prepared by the above method.

상기 산화반응은 피리디늄 클로로크로메이트에 의해 수행될 수 있다.
The oxidation reaction can be carried out by pyridinium chlorochromate.

상기 피리디늄 클로로크로메이트는 상기 감마-락톨에 대해 1 내지 5 당량으로 상기 산화반응에 첨가될 수 있다.
The pyridinium chlorochromate may be added to the oxidation reaction in an amount of 1 to 5 equivalents to the gamma-lactol.

본 발명의 또 다른 목적을 달성하고자 본 발명은,The present invention to achieve another object of the present invention,

상기 방법에 의해 제조된 감마-락톨을 환원시키는 환원반응 단계를 포함하는 3번 위치가 치환된 광학활성의 테트라히드로퓨란의 제조 방법을 제공한다.
Provided is a method for preparing an optically active tetrahydrofuran substituted at the 3rd position including a reduction step of reducing gamma-lactol prepared by the above method.

상기 환원반응은 트리플루오로보론에테르와 트리에틸실란에 의해 수행될 수 있다.
The reduction reaction can be carried out by trifluoroboron ether and triethylsilane.

상기 트리플루오로보론에테르와 트리에틸실란는 감마-락톨에 대해 1 내지 2 당량으로 상기 환원반응에 첨가될 수 있다.
The trifluoroboron ether and triethylsilane may be added to the reduction reaction in an amount of 1 to 2 equivalents based on gamma-lactol.

본 발명의 또 다른 목적을 달성하기 위하여 본 발명은,In order to achieve another object of the present invention,

상기 베타위치가 치환된 광학활성의 감마-락톤의 제조 방법에 의해 제조된 광학활성의 감마-락톤을 제공한다.
It provides an optically active gamma-lactone prepared by the method for producing an optically active gamma-lactone substituted with the beta position.

본 발명의 또 다른 목적을 달성하기 위하여 본 발명은In order to achieve another object of the present invention

상기 3번 위치가 치환된 광학활성의 테트라히드로퓨란의 제조 방법에 의해 제조된 광학활성의 테트라히드로퓨란을 제공한다.
Provided is an optically active tetrahydrofuran prepared by the method for producing an optically active tetrahydrofuran substituted with the 3-position.

본 발명의 제조 방법에 의해 종래보다 간단한 방법으로 베타위치가 치환된 광학활성의 감마-락톤과 3번 위치가 치환된 광학활성의 테트라히드로퓨란을 얻을 수 있다. 또한, 본 발명의 제조 방법에 의해 거울상 선택성이 높은 베타위치가 치환된 광학활성의 감마-락톤과 3번 위치가 치환된 광학활성의 테트라히드로퓨란을 얻을 수 있다.According to the production method of the present invention, an optically active gamma-lactone having a beta position and an optically active tetrahydrofuran having a 3 position substitution can be obtained by a simpler method than before. In addition, by the production method of the present invention, optically active gamma-lactone substituted with beta position with high enantioselectivity and tetrahydrofuran with optically substituted position 3 can be obtained.

본 발명의 제조 방법은 베타위치가 치환된 광학활성의 감마-락톤과 3번 위치가 치환된 광학활성의 테트라히드로퓨란의 수율이 높아 효율적이다. The production method of the present invention is efficient because the yields of the optically active gamma-lactone substituted at the beta position and the tetrahydrofuran of the optically substituted position 3 are high.

본 발명의 제조 방법은 값비싼 중금속 촉매를 사용하지 않으므로 비용이 절감되고 합성 후 잔류하는 금속촉매를 제거할 필요가 없다.
Since the production method of the present invention does not use an expensive heavy metal catalyst, cost is reduced and there is no need to remove the metal catalyst remaining after synthesis.

이하, 당업자가 용이하게 실시할 수 있도록 본 발명을 상세히 설명한다.
Hereinafter, the present invention will be described in detail so that those skilled in the art can easily practice.

우선, 베타위치가 치환된 광학활성의 감마-락톨의 제조 방법을 설명한다.First, a method for producing optically active gamma-lactol substituted with a beta position will be described.

본 발명의 베타위치가 치환된 광학활성의 감마-락톨의 제조 방법은 촉매반응 단계를 포함한다. 상기 방법에 의해 중금속 촉매를 사용하지 않고 종래보다 간단한 공정으로 거울상 선택성이 높은 베타 위치가 치환된 광학활성의 감마-락톨을 높은 수율로 합성할 수 있다.The method for preparing an optically active gamma-lactol substituted with the beta position of the present invention includes a catalytic reaction step. By the above method, the optically active gamma-lactol substituted with the beta position with high enantioselectivity can be synthesized in a high yield without using a heavy metal catalyst.

하기 반응식 1 은 상기 촉매반응 단계를 간략히 나타낸 것이다:Scheme 1 below outlines the catalysis step:

[반응식 1][Reaction Scheme 1]

Figure 112010000234329-pat00007
Figure 112010000234329-pat00007

상기 반응식 1 을 참조하면, 상기 촉매반응 단계는 인돌, 피롤 또는 아민기가 치환된 벤젠을 감마-히드록시 알파, 베타-불포화 알데히드(γ-hydroxyα,β-unsaturated aldehyde)에 키랄 아민 촉매의 존재하에 1,4-첨가 반응시키는 단계이다.Referring to Scheme 1, the catalysis step may be performed in the presence of a chiral amine catalyst in gamma-hydroxy alpha, beta-unsaturated aldehyde (gamma-hydroxy alpha, beta-unsaturated aldehyde) of benzene substituted with indole, pyrrole or amine group. , 4-addition reaction.

상기 인돌은 하기 화학식 1 로 표현될 수 있다:The indole may be represented by the following Chemical Formula 1:

[화학식 1][Formula 1]

Figure 112010000234329-pat00008
Figure 112010000234329-pat00008

상기 화학식 1 에서, R1은 탄소수 1 내지 14 의 치환 또는 비치환된 알킬기, 알릴기, 또는 아릴기에서 선택될 수 있으며, 바람직하게는 상기 알킬기는 메틸기일 수 있다. R2는 수소, 탄소수 1 내지 14 의 알킬기, 알콕시기 또는 할로젠기에서 선택될 수 있으며, 바람직하게는 상기 알킬기는 메틸기일 수 있다. In Formula 1, R 1 may be selected from a substituted or unsubstituted alkyl group, allyl group, or aryl group having 1 to 14 carbon atoms, and preferably, the alkyl group may be a methyl group. R 2 may be selected from hydrogen, an alkyl group having 1 to 14 carbon atoms, an alkoxy group or a halogen group, and preferably, the alkyl group may be a methyl group.

상기 피롤은 하기 화학식 2 로 표현될 수 있다:The pyrrole may be represented by the following Chemical Formula 2:

[화학식 2][Formula 2]

Figure 112010000234329-pat00009
Figure 112010000234329-pat00009

상기 화학식 2 에서 R3은 탄소수 1 내지 14 의 치환 또는 비치환된 알킬기, 알릴기, 아릴기에서 선택될 수 있으며, 상기 알킬기는 바람직하게는 메틸기이다.In Formula 2, R 3 may be selected from a substituted or unsubstituted alkyl group, allyl group, and aryl group having 1 to 14 carbon atoms, and the alkyl group is preferably a methyl group.

상기 아민기가 치환된 벤젠은 하기 화학식 3 으로 표현될 수 있다:Benzene substituted with the amine group may be represented by the following Formula 3:

[화학식 3](3)

Figure 112010000234329-pat00010
Figure 112010000234329-pat00010

상기 화학식 3 에서, R4 은 탄소수 1 내지 10 의 디알킬아민이고, R5 은 수소 또는 탄소수 1 내지 10 의 알킬알콕시이다.In Formula 3, R 4 Is dialkylamine having 1 to 10 carbon atoms, R 5 Is hydrogen or alkylalkoxy having 1 to 10 carbon atoms.

상기 감마-히드록시 알파, 베타-불포화 알데히드는 하기 화학식 4 로 표현될 수 있다:The gamma-hydroxy alpha, beta-unsaturated aldehyde may be represented by the following formula (4):

[화학식 4][Formula 4]

Figure 112010000234329-pat00011
Figure 112010000234329-pat00011

상기 1,4-첨가 반응에서 인돌, 피롤 또는 아민기가 치환된 벤젠과 감마-히드록시 알파, 베타 불포화 알데히드는 1:1 내지 1:3 의 몰비로 반응시킬 수 있다. 1:1 보다 낮은 비율로 반응시키는 경우 인돌, 피롤 또는 아민기가 치환된 벤젠의 1,4-첨가반응이 제대로 일어나지 않아 수율이 낮으며, 1:3 을 초과하는 경우 수율의 향상이 크지 않아 효율적이지 못하다.In the 1,4-addition reaction, benzene substituted with indole, pyrrole or amine group and gamma-hydroxy alpha, beta unsaturated aldehyde may be reacted in a molar ratio of 1: 1 to 1: 3. When reacting at a ratio lower than 1: 1, the yield is low because 1,4-addition reaction of benzene substituted with indole, pyrrole, or amine group does not occur properly. Can not do it.

상기 키랄 아민 촉매는 하기 화학식 5 또는 6 으로 표현되는 화합물 또는 이들의 혼합물일 수 있다:The chiral amine catalyst may be a compound represented by Formula 5 or 6 or a mixture thereof:

[화학식 5][Chemical Formula 5]

Figure 112010000234329-pat00012
Figure 112010000234329-pat00012

[화학식 6][Formula 6]

Figure 112010000234329-pat00013
Figure 112010000234329-pat00013

상기 키랄 아민 촉매는 인돌, 피롤 또는 아민기가 치환된 벤젠에 대하여 5 내지 20 몰% 로 첨가할 수 있다. 5 몰% 미만으로 첨가되면 촉매반응이 제대로 일어나지 않아 반응의 수율이 낮으며, 20 몰% 를 초과하여 첨가되는 경우 반응의 수율의 증가가 미미하여 효율적이지 못하다. The chiral amine catalyst may be added in an amount of 5 to 20 mol% with respect to benzene substituted with indole, pyrrole or an amine group. If it is added less than 5 mol%, the catalytic reaction does not occur properly, so the yield of the reaction is low, and when it is added more than 20 mol%, the increase in the yield of the reaction is inefficient, which is not efficient.

상기 촉매반응은 -40 내지 -10 ℃ 에서 유기용매하에서 진행된다. -40 ℃ 보다 낮은 온도에서 진행될 경우 반응 속도가 느려 반응시간이 길어지며, -10 ℃ 보다 높은 온도에서 진행될 경우 반응이 조기에 종결되어 반응 수율이 감소할 수 있다. 상기 유기용매는 메틸렌클로라이드, 벤젠, 디에틸에테르, 아세톤, 아세토니트릴, 톨루엔, 테트라히드로퓨란, 메탄올 및 이소프로판올로 이루어진 군으로부터 선택된 단독 또는 이들의 혼합물일 수 있다. 바람직하게는, 메틸렌클로라이드와 이소프로판올의 9:1 부피비 혼합물이 사용될 수 있다. 상기 유기용매의 농도는 0.1 내지 1.0 M 일 수 있으며, 바람직하게는 0.3 M 일 수 있다. 1.0 M을 초과하면 반응물의 용해가 제대로 일어나지 않으며, 0.1 M 미만이면 초과하면 반응속도가 느려질 수 있다.The catalysis is carried out in an organic solvent at -40 to -10 ° C. When the reaction temperature is lower than -40 ℃, the reaction rate is slow, and the reaction time is long. When the reaction temperature is higher than -10 ℃, the reaction is terminated prematurely, and the reaction yield may be decreased. The organic solvent may be a single or a mixture thereof selected from the group consisting of methylene chloride, benzene, diethyl ether, acetone, acetonitrile, toluene, tetrahydrofuran, methanol and isopropanol. Preferably, a 9: 1 volume ratio mixture of methylene chloride and isopropanol may be used. The concentration of the organic solvent may be 0.1 to 1.0 M, preferably 0.3 M. If it exceeds 1.0 M, the dissolution of the reactants does not occur properly. If it exceeds 0.1 M, the reaction rate may be slowed.

상기 촉매반응은 2 내지 50 시간 동안 진행될 수 있다. 바람직하게는 24 내지 48 시간 동안 진행될 수 있다. 2 시간 미만으로 수행되는 경우 감마-락톨의 수율이 저하되며, 50 시간을 초과하는 경우 수율의 향상없이 반응시간만 길어질 수 있다.The catalysis may be performed for 2 to 50 hours. Preferably it may proceed for 24 to 48 hours. If it is performed in less than 2 hours, the yield of gamma-lactol is lowered, and if it exceeds 50 hours, only the reaction time may be long without improving the yield.

상기 촉매반응에 산을 첨가할 수 있다. 산을 첨가하는 경우 거울상 선택성이 증가되므로 당업자의 필요에 따라 산을 첨가할 수 있다. 상기 산은 당업계에 공지된 것이 제한없이 사용될 수 있으며, 구체적으로는 황산, 염산, 인산, 질산, 탄산, 아세트산, 트리플루오르아세트산, 벤조산등이 있으며, 바람직하게는 트리플루오르아세트산을 사용할 수 있다. 상기 산의 농도는 사용된 촉매의 양과 같은 농도를 사용한다.
An acid may be added to the catalysis. The addition of acid increases the enantioselectivity so that acid can be added as needed by those skilled in the art. The acid may be used without limitation as is known in the art, specifically, sulfuric acid, hydrochloric acid, phosphoric acid, nitric acid, carbonic acid, acetic acid, trifluoroacetic acid, benzoic acid, and the like, and preferably trifluoroacetic acid may be used. The concentration of the acid uses the same concentration as the amount of catalyst used.

이하, 베타위치가 치환된 광학활성의 감마-락톤의 제조 방법을 설명한다. Hereinafter, a method for preparing an optically active gamma-lactone having a beta position substituted will be described.

본 발명의 베타위치가 치환된 광학활성의 감마-락톤은 산화반응 단계를 포함한다. The beta-substituted optically active gamma-lactone of the present invention comprises an oxidation step.

하기 반응식 2 는 상기 산화반응을 간략하게 나타낸 것이다:Scheme 2 briefly illustrates the oxidation reaction:

[반응식 2]Scheme 2

Figure 112010000234329-pat00014
Figure 112010000234329-pat00014

상기 반응식 2 를 참조하면, 상기 산화반응 단계는 상기에서 제조된 베타위치가 치환된 광학활성의 감마-락톨을 산화시켜 베타위치가 치환된 광학활성의 감마-락톤을 제조하는 단계이다. 상기 산화반응에 의해 감마-락톨로부터 손쉽게 감마-락톤을 얻을 수 있을 뿐만 아니라, 거울상 선택성이 높은 베타위치가 치환된 광학활성의 감마-락톤을 높은 수율로 얻을 수 있다.Referring to Scheme 2, the oxidation step is to prepare a gamma-lactone of the beta-substituted optical activity by oxidizing the gamma-lactol of the beta-substituted optical activity prepared above. Not only can gamma-lactone be easily obtained from gamma-lactol by the oxidation reaction, but also high yield of optically active gamma-lactone substituted with beta position with high enantioselectivity.

상기 산화반응은 다양한 산화제를 사용하여 수행될 수 있으며, 상기 산화제로는 바람직하게는 피리디늄 클로로크로메이트(pyridinium chlorochromate, PCC)를 사용할 수 있다. 상기 피리디늄 클로로크로메이트는 1 내지 5 M 로 첨가할 수 있으며, 바람직하게는 2 M 로 첨가할 수 있다. 1 M 미만으로 첨가되면 산화가 제대로 일어나지 않아 반응의 수율이 낮아지며, 5 M 을 초과하여 첨가되면 반응의 수율 상승효과가 미미하므로 효율적이지 못하다.
The oxidation reaction can be carried out using a variety of oxidizing agents, the oxidizing agent may be preferably used pyridinium chlorochromate (PCC). The pyridinium chlorochromate may be added at 1 to 5 M, preferably at 2 M. If the amount is less than 1 M, oxidation does not occur properly, and thus the yield of the reaction is lowered.

다음으로, 3번 위치가 치환된 광학활성의 테트라히드로퓨란의 제조 방법을 설명한다. Next, the manufacturing method of the optically active tetrahydrofuran by which position 3 was substituted is demonstrated.

본 발명의 3번 위치가 치환된 광학활성의 테트라히드로퓨란의 제조 방법은 환원반응 단계를 포함한다. 상기 방법에 의해 감마-락톨로부터 손쉽게 3번 위치가 치환된 테트라히드로퓨란을 얻을 수 있을 뿐만 아니라 거울상 선택성이 높은 3번 위치가 치환된 광학활성의 테트라히드로퓨란을 높은 수율로 얻을 수 있다. Method for producing an optically active tetrahydrofuran substituted in position 3 of the present invention includes a reduction reaction step. By the above method, tetrahydrofuran in which position 3 is easily substituted from gamma-lactol can be obtained as well as optically active tetrahydrofuran in position 3 having high enantioselectivity in high yield.

상기 환원반응 단계는 상기 베타위치가 치환된 광학활성의 감마-락톨을 환원시켜 3번 위치가 치환된 광학활성의 테트라히드로퓨란을 제조하는 단계이다. In the reducing step, the beta-substituted optically active gamma-lactol is reduced to prepare tetrahydrofuran having the 3-substituted optical activity.

하기 반응식 3 은 상기 환원반응을 간략하게 나타낸 것이다. Scheme 3 below briefly illustrates the reduction reaction.

[반응식 3]Scheme 3

Figure 112010000234329-pat00015
Figure 112010000234329-pat00015

상기 반응식 3 을 참조하면, 감마-락톨은 환원반응에 의해 쉽게 3번 위치가 치환된 광학활성의 테트라히드로퓨란으로 전환된다.Referring to Scheme 3, gamma-lactol is easily converted to optically active tetrahydrofuran substituted at position 3 by a reduction reaction.

상기 환원반응은 다양한 환원제를 사용하여 수행될 수 있으며, 상기 환원제로는 바람직하게는 트리플루오로보론에테르 및 트리에틸실란을 사용할 수 있다. 상기 트리플루오로보론에테르 및 트리에틸실란는 상기 감마-락톨에 대해 1 내지 2 당량으로 상기 환원반응에 첨가될 수 있다. 상기 트리플루오로보론에테르 및 트리에틸실란이 1 당량 미만으로 포함되는 경우 테트라히드로퓨란의 수율이 저하될 수 있으며, 2 당량을 초과하여 포함되는 경우 수율의 증가가 미미하여 비효율적이다.
The reduction reaction may be performed using various reducing agents, and as the reducing agent, trifluoroboron ether and triethylsilane may be preferably used. The trifluoroboron ether and triethylsilane may be added to the reduction reaction in an amount of 1 to 2 equivalents based on the gamma-lactol. When the trifluoroboron ether and triethylsilane is included in less than 1 equivalent, the yield of tetrahydrofuran may be lowered, and when included in excess of 2 equivalents, the increase in yield is insignificant and inefficient.

이하 실시예에 의하여 본 발명을 더욱 상세하게 설명하고자 한다. 단, 하기 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명의 범위를 한정하는 것은 아니다.
By the following examples will be described in more detail the present invention. However, the following examples are only for illustrating the present invention and do not limit the scope of the present invention.

<< 실시예Example 1> 인돌 베타위치 치환 감마- 1> indole beta substitution gamma- 락톨의Lactol 합성  synthesis

1-1. (4-(1-1-1. (4- (1- 메틸methyl -1H-인돌-3-일)-1H-indol-3-yl) 테트라히드로퓨란Tetrahydrofuran -2-올)의 합성2-ol)

N-메틸인돌 121 mg(1.0 mmol)과 상기 화학식 6 의 촉매 25 mg (0.10 mmol)을 플라스크에 담고, 메틸렌 클로라이드 1.8 ㎖ 와 이소프로판올 0.2 ㎖를 적가하였다. 이 반응 플라스크를 -40 ℃의 저온 반응기에 위치시키고, 1 N 트리플푸오로아세트산 0.1 ㎖(0.10 mmol)를 가하였다. 10 분간 교반한 후에 4-히드록시-2-부테날(4-hydroxy-but-2-enal) 170 mg (2.00 mmmol)을 주입하였다. 상기 반응 용액을 N-메틸인돌이 완전히 반응할 때까지 지속적으로 교반하였으며, 반응을 -40 ℃에서 24 시간 동안 수행하였다. 상기 반응이 완료되었음은 TLC(thin-layer chromatography)를 통해서 확인하였다. 이어서, 반응 결과물을 40% 에틸아세테이트/헥산으로 ICN 60 실리카 겔 63(32~64mesh)을 사용하는 강제-흐름 크로마토그래피(forced-flow chromatography)로 정제하여 무색의 표제 화합물을 얻었다(215 mg, 99% 수율).        121 mg (1.0 mmol) of N-methylindole and 25 mg (0.10 mmol) of the catalyst of Chemical Formula 6 were placed in a flask, and 1.8 ml of methylene chloride and 0.2 ml of isopropanol were added dropwise. The reaction flask was placed in a low temperature reactor at −40 ° C. and 0.1 mL (0.10 mmol) of 1 N triplefuoroacetic acid was added. After stirring for 10 minutes, 170 mg (2.00 mmmol) of 4-hydroxy-2-butenal was injected. The reaction solution was continuously stirred until N-methylindole was completely reacted, and the reaction was carried out at -40 ° C for 24 hours. The completion of the reaction was confirmed by thin-layer chromatography (TLC). The reaction product was then purified by forced-flow chromatography using ICN 60 silica gel 63 (32-64 mesh) with 40% ethyl acetate / hexanes to give a colorless title compound (215 mg, 99). % Yield).

1H NMR (300 MHz, CDCl3) 7.66 (d, J = 8.1 Hz, 0.4H), 7.60 (d, J = 7.8 Hz, 0.4H), 7.07-7.27 (m, 4H), 6.95 (s, 0.4H), 6.85 (s, 0.6H), 5.72 (d, J = 4.8 Hz, 1H), 4.50 (t, J = 7.8 Hz, 0.6H), 4.25 (t, J = 7.8 Hz, 0.4H), 3.88-4.12 (m, 2H), 3.71 (s, 3H), 2.10-2.77 (m, 3H); 13C NMR (75 MHz, CDCl3) 137.6, 137.5, 127.5, 127.3, 125.9, 125.5, 122.1, 121.7, 119.5, 119.4, 119.2, 119.1, 115.1, 114.2, 109.7, 109.6, 99. 6, 99.2, 73.4, 72.4, 40.9, 40.8, 36.3, 34.3, 32.9 1 H NMR (300 MHz, CDCl 3 ) 7.66 (d, J = 8.1 Hz, 0.4H), 7.60 (d, J = 7.8 Hz, 0.4H), 7.07-7.27 (m, 4H), 6.95 (s, 0.4 H), 6.85 (s, 0.6H), 5.72 (d, J = 4.8 Hz, 1H), 4.50 (t, J = 7.8 Hz, 0.6H), 4.25 (t, J = 7.8 Hz, 0.4H), 3.88 -4.12 (m, 2H), 3.71 (s, 3H), 2.10-2.77 (m, 3H); 13 C NMR (75 MHz, CDCl 3 ) 137.6, 137.5, 127.5, 127.3, 125.9, 125.5, 122.1, 121.7, 119.5, 119.4, 119.2, 119.1, 115.1, 114.2, 109.7, 109.6, 99. 6, 99.2, 73.4, 72.4, 40.9, 40.8, 36.3, 34.3, 32.9

1-2. (4-(1-알릴-1H-인돌-3-일)테트라히드로퓨란-2-올)의 합성1-2. Synthesis of (4- (1-allyl-1H-indol-3-yl) tetrahydrofuran-2-ol)

N-알릴인돌 39 mg (0.25 mmol)을 사용한 것을 제외하고는 상기 실시예 1-1 과 동일한 방법으로 감마-락톨을 합성하였다. 반응 결과물을 40% 에틸아세테이트/헥산에서 실리카 겔 크로마토그래피로 정제하여 무색의 감마-락톨을 얻었다(58 mg, 95% 수율).       Gamma-lactol was synthesized in the same manner as in Example 1-1, except that 39 mg (0.25 mmol) of N-allylyindole was used. The reaction product was purified by silica gel chromatography on 40% ethyl acetate / hexanes to give a colorless gamma-lactol (58 mg, 95% yield).

1H NMR (300 MHz, CDCl3) 7.64 (d, J = 8.1 Hz, 0.4H), 7.58 (d, J = 7.8 Hz, 0.4H), 7.11-7.29 (m, 4H), 6.93 (s, 0.4H), 6.85 (s, 0.6H), 5.70 (d, J = 4.8 Hz, 1H), 5.05-5.24 (m, 2H), 4.72 (d, J = 5.4 Hz, 2H), 4.52 (t, J = 7.8 Hz, 0.6H), 4.26 (t, J = 7.8 Hz, 0.4H), 3.88-4.12 (m, 2H), 2.10-2.77 (m, 3H); 13C NMR (75 MHz, CDCl3) 137.7, 137.6, 135.2, 127.2, 127.1, 125.8, 125.5, 122.0, 121.7, 119.6, 119.4, 119.1, 119.0, 117.2, 115.0, 114.7, 109.7, 109.5, 99. 3, 99.0, 73.2, 72.4, 51.3, 48.7, 48.5, 35.9, 34.2, 32.7 1 H NMR (300 MHz, CDCl 3 ) 7.64 (d, J = 8.1 Hz, 0.4H), 7.58 (d, J = 7.8 Hz, 0.4H), 7.11-7.29 (m, 4H), 6.93 (s, 0.4 H), 6.85 (s, 0.6H), 5.70 (d, J = 4.8 Hz, 1H), 5.05-5.24 (m, 2H), 4.72 (d, J = 5.4 Hz, 2H), 4.52 (t, J = 7.8 Hz, 0.6H), 4.26 (t, J = 7.8 Hz, 0.4H), 3.88-4.12 (m, 2H), 2.10-2.77 (m, 3H); 13 C NMR (75 MHz, CDCl 3 ) 137.7, 137.6, 135.2, 127.2, 127.1, 125.8, 125.5, 122.0, 121.7, 119.6, 119.4, 119.1, 119.0, 117.2, 115.0, 114.7, 109.7, 109.5, 99. 3, 99.0, 73.2, 72.4, 51.3, 48.7, 48.5, 35.9, 34.2, 32.7

1-3. (4-(1-벤질-1H-인돌-3-일)1-3. (4- (1-benzyl-1H-indol-3-yl) 테트라히드로퓨란Tetrahydrofuran -2-올)의 합성2-ol)

N-벤질인돌 52 mg (0.25 mmol)을 사용한 것을 제외하고는 상기 실시예 1-1 과 동일한 방법으로 감마-락톨을 합성하였다. 반응 결과물을 40% 에틸아세테이트/헥산에서 실리카 겔 크로마토그래피로 정제하여 무색의 감마-락톨을 얻었다(73 mg, 95% 수율).       Gamma-lactol was synthesized in the same manner as in Example 1-1, except that 52 mg (0.25 mmol) of N-benzylindole was used. The reaction product was purified by silica gel chromatography on 40% ethyl acetate / hexanes to give a colorless gamma-lactol (73 mg, 95% yield).

1H NMR (300 MHz, CDCl3) 7.06-7.66 (m, 9H), 6.94 (s, 0.4H), 6.86 (s, 0.6H), 5.74 (d, J = 4.8 Hz, 1H), 5.28, (s, 2H), 3.88-4.55 (m, 3H), 2.10-2.77 (m, 3H); 13C NMR (75 MHz, CDCl3) 137.7, 137.6, 131.8, 128.7, 127.9, 127.4, 127.3, 125.8, 125.5, 124.6, 122.0, 121.6, 119.6, 119.4, 119.2, 119.0, 115.0, 114.3, 109.8, 109.7, 98. 8, 98.7, 73.4, 72.4, 50.2, 50.1, 36.3, 34.3, 32.9 1 H NMR (300 MHz, CDCl 3 ) 7.06-7.66 (m, 9H), 6.94 (s, 0.4H), 6.86 (s, 0.6H), 5.74 (d, J = 4.8 Hz, 1H), 5.28, ( s, 2H), 3.88-4.55 (m, 3H), 2.10-2.77 (m, 3H); 13 C NMR (75 MHz, CDCl 3 ) 137.7, 137.6, 131.8, 128.7, 127.9, 127.4, 127.3, 125.8, 125.5, 124.6, 122.0, 121.6, 119.6, 119.4, 119.2, 119.0, 115.0, 114.3, 109.8, 109.7, 98. 8, 98.7, 73.4, 72.4, 50.2, 50.1, 36.3, 34.3, 32.9

1-4. (4-(1-벤질-5-1-4. (4- (1-benzyl-5- 메톡시Methoxy -1H-인돌-3-일)-1H-indol-3-yl) 테트라히드로퓨란Tetrahydrofuran -2-올)의 합성2-ol)

N-벤질-5-메톡시-인돌 60 mg (0.25 mmol)을 사용하고, -30 ℃에서 반응시킨 것을 제외하고는 상기 실시예 1-1 과 동일한 방법으로 감마-락톨을 합성하였다. 반응 결과물을 40% 에틸아세테이트/헥산에서 실리카 겔 크로마토그래피로 정제하여 무색의 감마-락톨을 얻었다(78 mg, 97% 수율).       Gamma-lactol was synthesized in the same manner as in Example 1-1, except that 60 mg (0.25 mmol) of N-benzyl-5-methoxy-indole was reacted at -30 ° C. The reaction product was purified by silica gel chromatography on 40% ethyl acetate / hexanes to give a colorless gamma-lactol (78 mg, 97% yield).

1H NMR (300 MHz, CDCl3) 7.05-7.70 (m, 8H), 6.88 (s, 0.4H), 6.76 (s, 0.6H), 5.84 (d, J = 4.5 Hz, 1H), 5.28, (s, 2H), 3.94 (s, 3H), 3.84-4.57 (m, 3H), 2.08-2.75 (m, 3H); 13C NMR (75 MHz, CDCl3) 154.3, 154.1, 138.1, 137.9, 131.6, 128.6, 127.3, 125.7, 125.4, 124.3, 119.8, 119.5, 119.0, 118.8, 115.2, 114.7, 109.6, 109.4, 98.8, 98.7, 73.4, 72.4, 59.3, 50.3, 50.2, 36.4, 34.3, 32.8 1 H NMR (300 MHz, CDCl 3 ) 7.05-7.70 (m, 8H), 6.88 (s, 0.4H), 6.76 (s, 0.6H), 5.84 (d, J = 4.5 Hz, 1H), 5.28, ( s, 2H), 3.94 (s, 3H), 3.84-4.57 (m, 3H), 2.08-2.75 (m, 3H); 13 C NMR (75 MHz, CDCl 3 ) 154.3, 154.1, 138.1, 137.9, 131.6, 128.6, 127.3, 125.7, 125.4, 124.3, 119.8, 119.5, 119.0, 118.8, 115.2, 114.7, 109.6, 109.4, 98.8, 98.7, 73.4, 72.4, 59.3, 50.3, 50.2, 36.4, 34.3, 32.8

1-5. (4-(1-벤질-5-1-5. (4- (1-benzyl-5- 벤질옥시Benzyloxy -1H-인돌-3-일)-1H-indol-3-yl) 테트라히드로퓨란Tetrahydrofuran -2-올)의 합성2-ol)

N-벤질-5-벤질옥시-인돌 78 mg (0.25 mmol)을 사용하고, -20 ℃에서 반응시킨 것을 제외하고는 상기 실시예 1-1 과 동일한 방법으로 감마-락톨을 합성하였다. 반응 결과물을 40% 에틸아세테이트/헥산에서 실리카 겔 크로마토그래피로 정제하여 무색의 감마-락톨을 얻었다(99 mg, 99% 수율).       Gamma-lactol was synthesized in the same manner as in Example 1-1, except that 78 mg (0.25 mmol) of N-benzyl-5-benzyloxy-indole was reacted at -20 ° C. The reaction product was purified by silica gel chromatography on 40% ethyl acetate / hexanes to give a colorless gamma-lactol (99 mg, 99% yield).

1H NMR (300 MHz, CDCl3) 7.07-7.72 (m, 13H), 6.85 (s, 0.4H), 6.77 (s, 0.6H), 5.88 (d, J = 4.8 Hz, 1H), 5.55, (s, 2H), 5.28, (s, 2H), 3.88-4.59 (m, 3H), 2.11-2.78 (m, 3H); 13C NMR (75 MHz, CDCl3) 154.3, 154.1,142.5, 138.0, 137.8, 131.5, 128.9, 127.0, 125.6, 125.4, 124.5, 119.8, 119.6, 119.0, 118.8, 115.0, 114.7, 109.7, 109.5, 98.9, 98.7, 79.3, 73.4, 72.7, 50.4, 50.2, 36.7, 34.5, 32.6 1 H NMR (300 MHz, CDCl 3 ) 7.07-7.72 (m, 13H), 6.85 (s, 0.4H), 6.77 (s, 0.6H), 5.88 (d, J = 4.8 Hz, 1H), 5.55, ( s, 2H), 5.28, (s, 2H), 3.88-4.59 (m, 3H), 2.11-2.78 (m, 3H); 13 C NMR (75 MHz, CDCl 3 ) 154.3, 154.1,142.5, 138.0, 137.8, 131.5, 128.9, 127.0, 125.6, 125.4, 124.5, 119.8, 119.6, 119.0, 118.8, 115.0, 114.7, 109.7, 109.5, 98.9, 98.7, 79.3, 73.4, 72.7, 50.4, 50.2, 36.7, 34.5, 32.6

1-6. (4-(1-벤질-5-1-6. (4- (1-benzyl-5- 브로모Bromo -1H-인돌-3-일)-1H-indol-3-yl) 테트라히드로퓨란Tetrahydrofuran -2-올)의 합성2-ol)

N-벤질-5-브로모-인돌 72 mg (0.25 mmol)을 사용하고, -20 ℃에서 반응시킨 것을 제외하고는 상기 실시예 1-1 과 동일한 방법으로 감마-락톨을 합성하였다. 반응 결과물을 30% 에틸아세테이트/헥산에서 실리카 겔 크로마토그래피로 정제하여 무색의 감마-락톨을 얻었다(47 mg, 51% 수율).       Gamma-lactol was synthesized in the same manner as in Example 1-1, except that 72 mg (0.25 mmol) of N-benzyl-5-bromo-indole was reacted at -20 ° C. The reaction product was purified by silica gel chromatography on 30% ethyl acetate / hexanes to give a colorless gamma-lactol (47 mg, 51% yield).

1H NMR (300 MHz, CDCl3) 7.10-7.67 (m, 8H), 6.90 (s, 0.4H), 6.85 (s, 0.6H), 5.77 (d, J = 4.5 Hz, 1H), 5.65, (s, 2H), 3.90-4.57 (m, 3H), 2.08-2.70 (m, 3H); 13C NMR (75 MHz, CDCl3) 138.9, 138.7, 131.5, 128.5, 127.7, 127.4, 127.3, 125.8, 125.5, 124.5, 122.1, 121.8, 119.7, 119.6, 119.1, 118.9, 115.0, 114.8, 109.7, 109.6, 98.7, 98.6, 73.7, 72.8, 50.3, 50.1, 36.5, 34.2, 32.7
1 H NMR (300 MHz, CDCl 3 ) 7.10-7.67 (m, 8H), 6.90 (s, 0.4H), 6.85 (s, 0.6H), 5.77 (d, J = 4.5 Hz, 1H), 5.65, ( s, 2H), 3.90-4.57 (m, 3H), 2.08-2.70 (m, 3H); 13 C NMR (75 MHz, CDCl 3 ) 138.9, 138.7, 131.5, 128.5, 127.7, 127.4, 127.3, 125.8, 125.5, 124.5, 122.1, 121.8, 119.7, 119.6, 119.1, 118.9, 115.0, 114.8, 109.7, 109.6, 98.7, 98.6, 73.7, 72.8, 50.3, 50.1, 36.5, 34.2, 32.7

<< 실시예Example 2> 피롤 베타위치 치환 감마- 2> pyrrole beta-substituted gamma- 락톨의Lactol 합성  synthesis

2-1. (4-(1-알릴-1H-피롤-3-일)테트라히드로퓨란-2-올)의 합성2-1. Synthesis of (4- (1-allyl-1H-pyrrol-3-yl) tetrahydrofuran-2-ol)

N-알릴피롤 54 mg (0.50 mmol)과 상기 화학식 6 의 촉매 13 mg (0.05 mmol)을 플라스크에 담고, 메틸렌 클로라이드 0.9 ㎖ 와 이소프로판올 0.1 ㎖를 적가하였다. 이 반응 플라스크를 -40 ℃의 저온 반응기에 위치시키고, 1 N 트리플푸오로아세트산 0.05 ㎖(0.05 mmol)를 가하였다. 10 분간 교반한 후에 4-히드록시-2-부테날(4-hydroxy-but-2-enal) 66 mg (0.75 mmmol)을 주입하였다. 상기 반응 용액을 N-아릴피롤이 완전히 반응할 때까지 지속적으로 교반하였으며, 반응을 -40 ℃에서 4시간 동안 수행하였다. 상기 반응이 완료되었음은 TLC(thin-layer chromatography)를 통해서 확인하였다. 이어서, 반응 결과물을 30% 에틸아세테이트/헥산으로 ICN 60 실리카 겔 63(32~64mesh)을 사용하는 강제-흐름 크로마토그래피(forced-flow chromatography)로 정제하여 무색의 표제 화합물을 얻었다(42 mg, 44% 수율).        54 mg (0.50 mmol) of N-allylpyrrole and 13 mg (0.05 mmol) of the catalyst of Chemical Formula 6 were added to the flask, and 0.9 ml of methylene chloride and 0.1 ml of isopropanol were added dropwise. The reaction flask was placed in a low temperature reactor at −40 ° C. and 0.05 mL (0.05 mmol) of 1 N triplefuoroacetic acid was added. After stirring for 10 minutes, 66 mg (0.75 mmmol) of 4-hydroxy-2-butenal was injected. The reaction solution was continuously stirred until the N-arylpyrrole completely reacted, and the reaction was carried out at -40 ° C for 4 hours. The completion of the reaction was confirmed by thin-layer chromatography (TLC). The reaction product was then purified by force-flow chromatography using ICN 60 silica gel 63 (32-64 mesh) with 30% ethyl acetate / hexanes to give a colorless title compound (42 mg, 44). % Yield).

1H NMR (300 MHz, CDCl3) 6.21-6.42 (m, 3H), 5.64 (d, J = 4.8 Hz, 1H), 5.05-5.24 (m, 2H), 4.26-4.73 (m, 3H), 3.78-4.10 (m, 2H), 2.15-2.75 (m, 3H); 13C NMR (75 MHz, CDCl3) 132.5, 129.7, 129.5, 122.4, 122.2, 116.2, 115.1, 114.2, 109.8, 109.6, 73.4, 72.4, 58.1, 57.8, 36.4, 34.4, 32.8 1 H NMR (300 MHz, CDCl 3 ) 6.21-6.42 (m, 3H), 5.64 (d, J = 4.8 Hz, 1H), 5.05-5.24 (m, 2H), 4.26-4.73 (m, 3H), 3.78 -4.10 (m, 2 H), 2.15-2.75 (m, 3 H); 13 C NMR (75 MHz, CDCl 3 ) 132.5, 129.7, 129.5, 122.4, 122.2, 116.2, 115.1, 114.2, 109.8, 109.6, 73.4, 72.4, 58.1, 57.8, 36.4, 34.4, 32.8

2-2. (4-(1-벤질-1H-피롤-3-일)2-2. (4- (1-benzyl-1H-pyrrol-3-yl) 테트라히드로퓨란Tetrahydrofuran -2-올)의 합성2-ol)

N-벤질인돌 40 mg (0.25 mmol)을 사용하는 것을 제외하고는 상기 실시예 2-1 과 동일한 방법으로 감마-락톨을 합성하였다. 반응 결과물을 30% 에틸아세테이트/헥산에서 실리카 겔 크로마토그래피로 정제하여 무색의 감마-락톨을 얻었다(25 mg, 42% 수율).       Gamma-lactol was synthesized in the same manner as in Example 2-1, except that 40 mg (0.25 mmol) of N-benzylindole was used. The reaction product was purified by silica gel chromatography on 30% ethyl acetate / hexanes to give a colorless gamma-lactol (25 mg, 42% yield).

1H NMR (300 MHz, CDCl3) 7.11-7.38 (m, 5), 6.24-6.45 (m, 3H), 5.66-5.72 (m, 1H), 5.11 (s, 2H), 3.75-4.44 (m, 3H), 2.10-2.78 (m, 3H); 13C NMR (75 MHz, CDCl3) 131.7, 129.7, 129.5, 128.7, 127.5, 124.4, 122.3, 122.0, 115.0, 114.5, 109.7, 109.5, 73.5, 72.7, 59.3, 59.1, 36.7, 34.0, 32.4
1 H NMR (300 MHz, CDCl 3 ) 7.11-7.38 (m, 5), 6.24-6.45 (m, 3H), 5.66-5.72 (m, 1H), 5.11 (s, 2H), 3.75-4.44 (m, 3H), 2.10-2.78 (m, 3H); 13 C NMR (75 MHz, CDCl 3 ) 131.7, 129.7, 129.5, 128.7, 127.5, 124.4, 122.3, 122.0, 115.0, 114.5, 109.7, 109.5, 73.5, 72.7, 59.3, 59.1, 36.7, 34.0, 32.4

<< 실시예Example 3>  3> 아민기를An amine group 가지는 벤젠으로 베타위치 치환된 감마- Branch is gamma-substituted by benzene 락톨의Lactol 합성  synthesis

3-1. (4-(4-디메틸아미노-2-3-1. (4- (4-dimethylamino-2- 메톡시페닐Methoxyphenyl )) 테트라히드로퓨란Tetrahydrofuran -2-올)의 합성2-ol)

N,N-디메틸-m-애니시딘 38 mg (0.25 mmol)과 상기 화학식 6의 촉매 13 mg (0.05 mmol)을 플라스크에 담고, 메틸렌 클로라이드 0.5 ㎖를 적가하였다. 이 반응 플라스크를 -10 의 저온 반응기에 위치시키고, 1 N 트리플푸오로아세트산 0.05 ㎖(0.05 mmol)를 가하였다. 10 분간 교반한 후에 4-히드록시-2-부테날(4-hydroxy-but-2-enal) 43 mg (0.38 mmmol)을 주입하였다. 상기 반응 용액을 N,N-디메틸-m-애니시딘이 완전히 반응할 때까지 지속적으로 교반하였으며, 반응을 -10 ℃에서 36 시간 동안 수행하였다. 상기 반응이 완료되었음은 TLC(thin-layer chromatography)를 통해서 확인하였다. 이어서, 반응 결과물을 30% 에틸아세테이트/헥산으로 ICN 60 실리카 겔 63(32~64mesh)을 사용하는 강제-흐름 크로마토그래피(forced-flow chromatography)로 정제하여 무색의 표제 화합물을 얻었다(57 mg, 97% 수율).        38 mg (0.25 mmol) of N, N-dimethyl-m-anisidine and 13 mg (0.05 mmol) of the catalyst of Chemical Formula 6 were added to the flask, and 0.5 ml of methylene chloride was added dropwise. The reaction flask was placed in a -10 low temperature reactor and 0.05 mL (0.05 mmol) of 1N triplefuoroacetic acid was added. After stirring for 10 minutes, 43 mg (0.38 mmmol) of 4-hydroxy-2-butenal was injected. The reaction solution was continuously stirred until N, N-dimethyl-m-anisidine was completely reacted, and the reaction was carried out at -10 ° C for 36 hours. The completion of the reaction was confirmed by thin-layer chromatography (TLC). The reaction product was then purified by forced-flow chromatography using ICN 60 silica gel 63 (32-64mesh) with 30% ethyl acetate / hexanes to give a colorless title compound (57 mg, 97 % Yield).

1H NMR (300 MHz, CDCl3) 7.03 (d, J = 7.8 Hz, 1H),6.25-6.43 (m, 2H), 5.66 (d, J = 4.8 Hz, 1H), 3.83 (s, 3H), 3.74-4.12 (m, 3H), 2.94 (s, 6H), 2.11-2.74 (m, 3H); 13C NMR (75 MHz, CDCl3) 157.3, 157.1, 150.9, 150.4, 127.5, 127.3, 121.7, 121.5, 115.3, 115.0, 96.9, 96.8, 73.5, 72.7, 55.4, 41.0, 36.3, 34.1, 32.6 1 H NMR (300 MHz, CDCl 3 ) 7.03 (d, J = 7.8 Hz, 1H), 6.25-6.43 (m, 2H), 5.66 (d, J = 4.8 Hz, 1H), 3.83 (s, 3H), 3.74-4.12 (m, 3H), 2.94 (s, 6H), 2.11-2.74 (m, 3H); 13 C NMR (75 MHz, CDCl 3 ) 157.3, 157.1, 150.9, 150.4, 127.5, 127.3, 121.7, 121.5, 115.3, 115.0, 96.9, 96.8, 73.5, 72.7, 55.4, 41.0, 36.3, 34.1, 32.6

3-2. (4-(4-3-2. (4- (4- 디벤질아미노Dibenzylamino -2--2- 메톡시페닐Methoxyphenyl )) 테트라히드로퓨란Tetrahydrofuran -2-올)의 합성2-ol)

N,N-디밴질-m-애니시딘 76 mg (0.25 mmol)을 사용하는 것을 제외하고는 상기 실시예 3-1 과 동일한 방법으로 감마-락톨을 합성하였다. 반응 결과물을 30% 에틸아세테이트/헥산에서 실리카 겔 크로마토그래피로 정제하여 무색의 감마-락톨을 얻었다(37 mg, 38% 수율).        Gamma-lactol was synthesized in the same manner as in Example 3-1, except that 76 mg (0.25 mmol) of N, N-dibenzyl-m-anisidine was used. The reaction product was purified by silica gel chromatography on 30% ethyl acetate / hexanes to give a colorless gamma-lactol (37 mg, 38% yield).

1H NMR (300 MHz, CDCl3) 7.11-7.39 (m, 10H), 6.96 (d, J = 8.2 Hz, 1H), 6.23-6.44 (m, 2H), 5.68 (d, J = 4.5 Hz, 1H), 4.63 (s, 4H), 3.72-4.13 (m, 3H), 3.62 (s, 3H), 2.14-2.75 (m, 3H); 13C NMR (75 MHz, CDCl3) 156.4, 156.2, 149.7, 149.6, 137.2, 127.0, 125.9, 125.5, 125.4, 125.1, 122.7, 122.5, 113.2, 113.0, 95.8, 95.7, 73.7, 72.9, 53.7, 53.2, 36.5, 34.7, 32.8 1 H NMR (300 MHz, CDCl 3 ) 7.11-7.39 (m, 10H), 6.96 (d, J = 8.2 Hz, 1H), 6.23-6.44 (m, 2H), 5.68 (d, J = 4.5 Hz, 1H ), 4.63 (s, 4H), 3.72-4.13 (m, 3H), 3.62 (s, 3H), 2.14-2.75 (m, 3H); 13 C NMR (75 MHz, CDCl 3 ) 156.4, 156.2, 149.7, 149.6, 137.2, 127.0, 125.9, 125.5, 125.4, 125.1, 122.7, 122.5, 113.2, 113.0, 95.8, 95.7, 73.7, 72.9, 53.7, 53.2, 36.5, 34.7, 32.8

상기 실시예 1 내지 2에 의해 합성된 베타 위치가 치환된 감마-락톤을 하기 표 1 에 나타내었다. The gamma-lactone substituted with the beta position synthesized by Examples 1 to 2 is shown in Table 1 below.

Figure 112010000234329-pat00016
Figure 112010000234329-pat00016

Figure 112010000234329-pat00017
Figure 112010000234329-pat00017

Figure 112010000234329-pat00018
Figure 112010000234329-pat00018

<< 실시예Example 4> 베타위치가 치환된 감마-락톤(4-(1- 4> gamma-lactone substituted with beta position (4- (1- 메틸methyl -1H-인돌-3-일)-1H-indol-3-yl) 디히드로퓨란Dihydrofuran -2-온)의 합성 2-one)

상기 실시예 1-1에서 합성된 4-(1-메틸-1H-인돌-3-일)테트라히드로퓨란-2-올 43 mg (0.20 mmol)에 메틸렌 클로라이드 1.0 ㎖를 적가하였다. 이어 상온에서 피리디듐 클로로메이트를 첨가하였다. 2 시간 후에 추가적으로 1 당량의 피리디늄 클로라이드를 첨가하였다. 24 시간 후에 결과물을 10% 에틸아세테이트/헥산에서 실리카 겔 크로마토그래피로 정제하여 무색의 표제 화합물을 얻었다 (28 mg, 65% 수율). 1.0 ml of methylene chloride was added dropwise to 43 mg (0.20 mmol) of 4- (1-methyl-1H-indol-3-yl) tetrahydrofuran-2-ol synthesized in Example 1-1. Then pyrididium chloromate was added at room temperature. After 2 hours additional 1 equivalent of pyridinium chloride was added. After 24 hours, the resulting mixture was purified from 10% ethyl acetate / hexanes. Purification by silica gel chromatography gave the title compound as a colorless (28 mg, 65% yield).

1H NMR (300 MHz, CDCl3) 7.53 (dd, J = 0.9, 7.8 Hz, 1H), 7.11-7.35 (m, 3H), 6.93 (s, 1H), 4.72 (t, J = 7.8 Hz, 1H), 4.30 (t J = 7.5 Hz, 1H), 3.98-4.10 (m, 1H), 3.77 (s, 3H), 2.71-3.00 (m, 2H); 13C NMR (75 MHz, CDCl3) 177.2, 137.6, 126.6, 125.6, 122.5, 119.7, 118.8, 113.2, 110.0, 73.9, 35.5, 33.4, 33.0
1 H NMR (300 MHz, CDCl 3 ) 7.53 (dd, J = 0.9, 7.8 Hz, 1H), 7.11-7.35 (m, 3H), 6.93 (s, 1H), 4.72 (t, J = 7.8 Hz, 1H ), 4.30 (t J = 7.5 Hz, 1 H), 3.98-4.10 (m, 1 H), 3.77 (s, 3 H), 2.71-3.00 (m, 2H); 13 C NMR (75 MHz, CDCl 3 ) 177.2, 137.6, 126.6, 125.6, 122.5, 119.7, 118.8, 113.2, 110.0, 73.9, 35.5, 33.4, 33.0

<< 실시예Example 5> 3번 위치가 치환된 테트라히드로퓨란(1- 5> tetrahydrofuran substituted in position 3 (1- 메틸methyl -3-(-3- ( 테트라히드로퓨란Tetrahydrofuran -3-일)-1H--3-yl) -1H- indoleindole )의 합성 ) Synthesis of

상기 실시예 1-1에서 합성된 4-(1-메틸-1H-인돌-3-일)테트라히드로퓨란-2-올 33 mg (0.15 mmol)에 메틸렌 클로라이드 0.8 ㎖를 적가하였다. 이 반응 용액에 트리에틸실란 48 ㎕ (0.30 mmol)을 첨가한 후 -40 ℃의 저온 반응기에 위치시키고, 트리플루오로보론에테르 55 ㎕ (0.45 mmol)을 첨가하였다. 이 온도에서 10분간 교반 후 상온으로 온도를 올려 추가로 3 시간 동안 교반한 후, 물과 메틸렌 클로라이드로 추출하고, 추출액을 포화 소듐하이드로겐카보네이트 및 소금물로 세척하였다. 유기층을 무수 마그네슘 설페이트로 건조시키고, 여과 및 감압 농축한 후, 10% 에틸아세테이트/헥산에서 실리카 겔 크로마토그래피로 정제하여 무색의 표제 화합물을 얻었다 (20 mg, 67% 수율). To 33 mg (0.15 mmol) of 4- (1-methyl-1H-indol-3-yl) tetrahydrofuran-2-ol synthesized in Example 1-1, 0.8 ml of methylene chloride was added dropwise. 48 μl (0.30 mmol) of triethylsilane was added to the reaction solution, which was then placed in a low temperature reactor at −40 ° C., and 55 μl (0.45 mmol) of trifluoroboron ether was added thereto. After stirring at this temperature for 10 minutes, the temperature was raised to room temperature, followed by further stirring for 3 hours, followed by extraction with water and methylene chloride, and the extract was washed with saturated sodium hydrogen carbonate and brine. The organic layer was dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure, and then in 10% ethyl acetate / hexanes. Purification by silica gel chromatography gave the title compound as a colorless (20 mg, 67% yield).

1H NMR (300 MHz, CDCl3) 7.66 (d, J = 6.0 Hz, 1H), 7.26-7.35 (m, 2H), 7.15 (dd, J = 0.9, 6.0 Hz, 1H), 6.92 (s, 1H), 4.25 (t, J = 5.7 Hz, 1H), 4.10 (dt, J = 3.6, 6.0 Hz, 1H), 4.00 (q, J = 5.7 Hz, 1H), 3.86 (t, J = 5.7 Hz, 1H), 3.78 (s, 3H), 3.71 (t, J = 5.7 Hz, 1H), 2.37-2.48 (m, 1H), 2.08-2.17 (m, 1H); 13C NMR (75 MHz, CDCl3) 137.2, 127.2, 125.2, 121.8, 119.2, 118.8, 115.6, 109.4, 73.7, 68.2, 36.4, 33.4, 32.7 1 H NMR (300 MHz, CDCl 3 ) 7.66 (d, J = 6.0 Hz, 1H), 7.26-7.35 (m, 2H), 7.15 (dd, J = 0.9, 6.0 Hz, 1H), 6.92 (s, 1H ), 4.25 (t, J = 5.7 Hz, 1H), 4.10 (dt, J = 3.6, 6.0 Hz, 1H), 4.00 (q, J = 5.7 Hz, 1H), 3.86 (t, J = 5.7 Hz, 1H ), 3.78 (s, 3H), 3.71 (t, J = 5.7 Hz, 1H), 2.37-2.48 (m, 1H), 2.08-2.17 (m, 1H); 13 C NMR (75 MHz, CDCl 3 ) 137.2, 127.2, 125.2, 121.8, 119.2, 118.8, 115.6, 109.4, 73.7, 68.2, 36.4, 33.4, 32.7

<< 실험예Experimental Example 1>  1> 실시예Example 1 내지 3의 감마- Gamma of 1 to 3 락톨의Lactol 거울상 선택성의 확인 Confirmation of Mirror Image Selectivity

상기 실시예 1 내지 3 에서 합성된 감마-락톨은 실시 예 4의 방법을 통해 감카-락톤을 만든 후 키랄 HPLC를 사용하여 거울상 선택성을 측정하였다. 컬럼은 다음과 같은 Chiralcel 컬럼을 사용하였다: OD-H (25 cm), OD guard (5 cm), AD (25 cm) 및 AD guard (5 cm). 그 결과는 하기 표 2 와 같다.Gamma-lactol synthesized in Examples 1 to 3 was prepared by gamma-lactone through the method of Example 4, and then subjected to enantioselectivity using chiral HPLC. The column used a Chiralcel column as follows: OD-H (25 cm), OD guard (5 cm), AD (25 cm) and AD guard (5 cm). The results are shown in Table 2 below.

Figure 112010000234329-pat00019
Figure 112010000234329-pat00019

각 실시예의 HPLC 조건은 하기와 같다.HPLC conditions of each Example are as follows.

실시예 1-1: AD-H 컬럼, 10% 이소프로판올/헥산, 1.0 ㎖/min flow, λ= 220 nm; minor isomer t r = 15.4 min, major isomer t r = 17.3 min.Example 1-1 AD-H column, 10% isopropanol / hexanes, 1.0 mL / min flow, lambda = 220 nm; minor isomer t r = 15.4 min, major isomer t r = 17.3 min.

실시예 1-2: AD-H 컬럼, 10% 이소프로판올/헥산, 1.0 ㎖/min flow, λ= 220 nm; minor isomer t r = 12.6 min, major isomer t r = 13.5 min.Example 1-2 AD-H column, 10% isopropanol / hexanes, 1.0 mL / min flow, lambda = 220 nm; minor isomer t r = 12.6 min, major isomer t r = 13.5 min.

실시예 1-3: AD-H 컬럼, 10% 이소프로판올/헥산, 1.2 ㎖/min flow, λ= 220 nm; minor isomer t r = 18.9 min, major isomer t r = 21.4 min.Examples 1-3: AD-H column, 10% isopropanol / hexanes, 1.2 ml / min flow, lambda = 220 nm; minor isomer t r = 18.9 min, major isomer t r = 21.4 min.

실시예 1-4: AD-H 컬럼, 10% 이소프로판올/헥산, 1.2 ㎖/min flow, λ= 220 nm; minor isomer t r = 25.3 min, major isomer t r = 27.2 min.Examples 1-4: AD-H column, 10% isopropanol / hexanes, 1.2 ml / min flow, lambda = 220 nm; minor isomer t r = 25.3 min, major isomer t r = 27.2 min.

실시예 1-5: AD-H 컬럼, 10% 이소프로판올/헥산, 1.2 ㎖/min flow, λ= 220 nm; minor isomer t r = 40.2 min, major isomer t r = 44.3 min.Example 1-5 AD-H column, 10% isopropanol / hexanes, 1.2 mL / min flow, λ = 220 nm; minor isomer t r = 40.2 min, major isomer t r = 44.3 min.

실시예 1-6: AD-H 컬럼, 10% 이소프로판올/헥산, 1.0 ㎖/min flow, λ= 220 nm; minor isomer t r = 23.1 min, major isomer t r = 27.2 min.Examples 1-6: AD-H column, 10% isopropanol / hexanes, 1.0 mL / min flow, lambda = 220 nm; minor isomer t r = 23.1 min, major isomer t r = 27.2 min.

실시예 2-1: AD-H 컬럼, 2% 이소프로판올/헥산, 1.0 ㎖/min flow, λ= 220 nm; major isomer t r = 44.4 min, minor isomer t r = 49.7 min.Example 2-1: AD-H column, 2% isopropanol / hexanes, 1.0 mL / min flow, lambda = 220 nm; major isomer t r = 44.4 min, minor isomer t r = 49.7 min.

실시예 2-2: OD-H 컬럼, 10% 이소프로판올/헥산, 1.0 ㎖/min flow, λ= 220 nm; minor isomer t r = 63.8 min, major isomer t r = 69.5 min.Example 2-2: OD-H column, 10% isopropanol / hexanes, 1.0 mL / min flow, lambda = 220 nm; minor isomer t r = 63.8 min, major isomer t r = 69.5 min.

실시예 3-1; AD-H 컬럼, 10% 이소프로판올/헥산, 1.0 ㎖/min flow, λ= 220 nm; major isomer t r = 11.6 min, minor isomer t r = 13.3 min.Example 3-1; AD-H column, 10% isopropanol / hexane, 1.0 mL / min flow, λ = 220 nm; major isomer t r = 11.6 min, minor isomer t r = 13.3 min.

실시예 3-2: AD-H 컬럼, 10% 이소프로판올/헥산, 1.0 ㎖/min flow, λ= 220 nm; minor isomer t r = 20.8 min, major isomer t r = 23.8 min.Example 3-2: AD-H column, 10% isopropanol / hexanes, 1.0 mL / min flow, lambda = 220 nm; minor isomer t r = 20.8 min, major isomer t r = 23.8 min.

상기에서 살펴본 바와 같이, 본 발명의 제조 방법에 의하면 거울상 선택성이 높은 베타위치가 치환된 광학활성의 감마-락톤과 3번 위치가 치환된 광학활성의 테트라히드로퓨란을 높은 수율로 얻을 수 있다. 또한, 제조 방법이 종래에 비해 간단하여 보다 손쉽게 베타위치가 치환된 광학활성의 감마-락톤과 3번 위치가 치환된 광학활성의 테트라히드로퓨란을 얻을 수 있을 뿐더러, 금속촉매를 사용하지 않아 별도의 금속촉매 제거 공정이 필요하지 않다. As described above, according to the production method of the present invention, optically active gamma-lactone substituted with beta position with high enantioselectivity and tetrahydrofuran with substituted third position in optical yield can be obtained. In addition, the manufacturing method is simpler than the conventional method, and thus it is easier to obtain optically active gamma-lactone in which the beta position is substituted and tetrahydrofuran in the third position is substituted, and a metal catalyst is not used. No metal catalyst removal process is necessary.

Claims (15)

인돌, 피롤 또는 아민기가 치환된 벤젠을 감마-히드록시 알파, 베타-불포화 알데히드에 키랄 아민 촉매의 존재하에 1,4-첨가반응시키는 촉매반응 단계를 포함하는 베타위치가 치환된 광학활성의 감마-락톨의 제조 방법에 있어서,
상기 인돌이 하기 화학식 1로 표현되고,
[화학식 1]
Figure 112012024977051-pat00020

(화학식 1 에서,
R1 은 메틸기, 알릴기 또는 벤질기이며,
R2 는 수소, 메톡시기, 벤질옥실기 또는 브로모기이다.)
상기 피롤이 하기 화학식 2로 표현되며,
[화학식 2]
Figure 112012024977051-pat00021

(화학식 2 에서,
R3 은 알릴기 또는 벤질기이다)

상기 아민기가 치환된 벤젠이 하기 화학식 3으로 표현되고,
[화학식 3]
Figure 112012024977051-pat00022

(상기 화학식 3 에서,
(R4 은 디메틸아민 또는 디벤질아민이며,
R5 은 메톡시기이다.)
상기 감마-히드록시 알파, 베타-불포화 알데히드가 하기 화학식 4로 표현되며,
[화학식 4]
Figure 112012024977051-pat00023


상기 키랄 아민 촉매가 하기 화학식 6으로 표현되는 화합물이고,
[화학식 6]
Figure 112012024977051-pat00025

상기 베타위치가 치환된 광학활성의 감마-락톨이 하기의 화학식 1-1 내지 3-2로 표현되는 것을 특징으로 하는 베타위치가 치환된 광학활성의 감마-락톨의 제조 방법:
[화학식 1-1]

Figure 112012024977051-pat00026

[화학식 1-2]
Figure 112012024977051-pat00027

[화학식 1-3]
Figure 112012024977051-pat00028

[화학식 1-4]
Figure 112012024977051-pat00029

[화학식 1-5]
Figure 112012024977051-pat00030


[화학식 1-6]

Figure 112012024977051-pat00031

[화학식 2-1]
Figure 112012024977051-pat00032

[화학식 2-2]

Figure 112012024977051-pat00033


[화학식 3-1]
Figure 112012024977051-pat00034


[화학식 3-2]
Figure 112012024977051-pat00035
Beta-substituted optically active gamma comprising a catalysis step of adding 1,4-addition reaction of indole, pyrrole or amine-substituted benzene to gamma-hydroxy alpha, beta-unsaturated aldehyde in the presence of a chiral amine catalyst. In the manufacturing method of lactol,
The indole is represented by the following Formula 1,
[Formula 1]
Figure 112012024977051-pat00020

(In Formula 1,
R 1 is a methyl group, allyl group or benzyl group,
R 2 is hydrogen, methoxy, benzyloxyl or bromo.)
The pyrrole is represented by the following formula (2),
(2)
Figure 112012024977051-pat00021

(In Formula 2,
R 3 is an allyl group or benzyl group)

Benzene substituted with the amine group is represented by the following formula (3),
(3)
Figure 112012024977051-pat00022

(In Chemical Formula 3,
(R 4 is dimethylamine or dibenzylamine,
R 5 is a methoxy group.)
The gamma-hydroxy alpha, beta-unsaturated aldehyde is represented by the following formula (4),
[Chemical Formula 4]
Figure 112012024977051-pat00023


The chiral amine catalyst is a compound represented by the following formula (6),
[Chemical Formula 6]
Figure 112012024977051-pat00025

Method for producing a beta-substituted optically active gamma-lactol, characterized in that the beta-substituted optically active gamma-lactol is represented by the following formula 1-1 to 3-2:
[Formula 1-1]

Figure 112012024977051-pat00026

[Formula 1-2]
Figure 112012024977051-pat00027

[Formula 1-3]
Figure 112012024977051-pat00028

[Formula 1-4]
Figure 112012024977051-pat00029

[Formula 1-5]
Figure 112012024977051-pat00030


[Formula 1-6]

Figure 112012024977051-pat00031

[Formula 2-1]
Figure 112012024977051-pat00032

[Formula 2-2]

Figure 112012024977051-pat00033


[Formula 3-1]
Figure 112012024977051-pat00034


[Formula 3-2]
Figure 112012024977051-pat00035
삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 제1항에 있어서,
상기 촉매반응이 -40 내지 -10 ℃ 에서 2 내지 50 시간 동안 유기용매에서 진행되는 것을 특징으로 하는 베타위치가 치환된 광학활성의 감마-락톨의 제조 방법.
The method of claim 1,
Method for producing a beta-substituted optically active gamma-lactol, characterized in that the catalytic reaction is carried out in an organic solvent for 2 to 50 hours at -40 to -10 ℃.
제7항에 있어서,
상기 유기용매가 메틸렌클로라이드, 벤젠, 디에틸에테르, 아세톤, 아세토니트릴, 톨루엔, 테트라히드로푸란, 메탄올 및 이소프로판올로 이루어진 군으로부터 선택된 단독 또는 이들의 혼합물인 것을 특징으로 하는 베타위치가 치환된 광학활성의 감마-락톨의 제조 방법.
The method of claim 7, wherein
Wherein the organic solvent is methylene chloride, benzene, diethyl ether, acetone, acetonitrile, toluene, tetrahydrofuran, methanol and isopropanol alone or a mixture thereof. Method for preparing gamma-lactol.
제1항의 방법으로 제조된 감마-락톨을 산화시키는 산화반응 단계를 포함하는 것을 특징으로 하는 베타 위치가 치환된 광학활성의 감마-락톤의 제조 방법. A method for preparing an optically active gamma-lactone having a beta position substituted by oxidizing the gamma-lactol prepared by the method of claim 1. 제9항에 있어서,
상기 산화반응이 피리디늄 클로로크로메이트에 의해 진행되는 것을 특징으로 하는 베타 위치가 치환된 광학활성의 감마-락톤의 제조 방법.
10. The method of claim 9,
Method of producing a beta-substituted optically active gamma-lactone, characterized in that the oxidation proceeds by pyridinium chlorochromate.
제1항의 방법으로 제조된 감마-락톨을 환원시키는 환원반응 단계를 포함하는 것을 특징으로 하는 3번 위치가 치환된 광학활성의 테트라히드로퓨란의 제조 방법. A method for producing an optically active tetrahydrofuran substituted at position 3, comprising the step of reducing the gamma-lactol prepared by the method of claim 1. 제11항에 있어서,
상기 환원반응이 트리플루오로보론에테르와 트리에틸실란에 의해 진행되는 것을 특징으로 하는 3번 위치가 치환된 광학활성의 테트라히드로퓨란의 제조 방법.
The method of claim 11,
Method for producing an optically active tetrahydrofuran substituted at the 3 position, characterized in that the reduction reaction is carried out by trifluoroboron ether and triethylsilane.
제1항, 제7항 및 제8항 중 어느 한 항의 방법으로 제조된 것을 특징으로 하는 베타위치가 치환된 광학활성의 감마-락톨.A beta-substituted optically active gamma-lactol, which is prepared by the method of any one of claims 1, 7 and 8. 제9항 또는 제10항의 방법으로 제조된 것을 특징으로 하는 베타위치가 치환된 광학활성의 감마-락톤.A beta-substituted optically active gamma-lactone, which is prepared by the method of claim 9 or 10. 제11항 또는 제12항의 방법으로 제조된 것을 특징으로 하는 3번 위치가 치환된 광학활성의 테트라히드로퓨란.An optically active tetrahydrofuran substituted at position 3, which is prepared by the method according to claim 11 or 12.
KR1020100000243A 2010-01-04 2010-01-04 Method of preparing ß-sustituted chiral g-lactol,g-lactone and 3-substituted chiral tetrahydrofurane and chiral g-lactol, g-lactone and chiral tetrahydrofurane prepared by thereof KR101165891B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020100000243A KR101165891B1 (en) 2010-01-04 2010-01-04 Method of preparing ß-sustituted chiral g-lactol,g-lactone and 3-substituted chiral tetrahydrofurane and chiral g-lactol, g-lactone and chiral tetrahydrofurane prepared by thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100000243A KR101165891B1 (en) 2010-01-04 2010-01-04 Method of preparing ß-sustituted chiral g-lactol,g-lactone and 3-substituted chiral tetrahydrofurane and chiral g-lactol, g-lactone and chiral tetrahydrofurane prepared by thereof

Publications (2)

Publication Number Publication Date
KR20110080077A KR20110080077A (en) 2011-07-12
KR101165891B1 true KR101165891B1 (en) 2012-07-13

Family

ID=44919085

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100000243A KR101165891B1 (en) 2010-01-04 2010-01-04 Method of preparing ß-sustituted chiral g-lactol,g-lactone and 3-substituted chiral tetrahydrofurane and chiral g-lactol, g-lactone and chiral tetrahydrofurane prepared by thereof

Country Status (1)

Country Link
KR (1) KR101165891B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101459184B1 (en) * 2012-03-21 2014-11-07 경기대학교 산학협력단 SYNTHESIS OF 4-SUBSTITUTED CHIRAL CHROMANOLS BY USING MALONIC ESTER AND O-HYDROXYAROMATIC α,β-UNSATURATED ALDEHYDES

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236438A1 (en) * 2001-06-29 2003-12-25 Macmillan David W.C. Enantioselective 1,4-addition of aromatic nucleophiles to alpha,beta-unsaturated aldehydes using chiral organic catalysts

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236438A1 (en) * 2001-06-29 2003-12-25 Macmillan David W.C. Enantioselective 1,4-addition of aromatic nucleophiles to alpha,beta-unsaturated aldehydes using chiral organic catalysts

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Journal of Organic Chemistry , 58, pp. 2725-2737. (1993) *
Journal of Organic Chemistry , 59, pp. 434-441. (1994) *

Also Published As

Publication number Publication date
KR20110080077A (en) 2011-07-12

Similar Documents

Publication Publication Date Title
JP5849710B2 (en) Process for producing β-fluoroalcohols
CA2099444C (en) Process for preparing tert-butyl (3r,5s)-6-hydroxy-3,5-o- isopropylidene-3,5-dihydroxyhexanoate
EP0385733A2 (en) Process for preparing optically active 6-t-butoxy-3,5-dihydroxyhexanoic esters
EP2054363B1 (en) Asymmetric hydrogenation of 1,1,1-trifluoroacetone
JP2009091257A (en) Method for preparing michael reaction product using asymmetric catalyst
KR20020009485A (en) Process for producing optically active alcohol
KR101165891B1 (en) Method of preparing ß-sustituted chiral g-lactol,g-lactone and 3-substituted chiral tetrahydrofurane and chiral g-lactol, g-lactone and chiral tetrahydrofurane prepared by thereof
JP5564715B2 (en) Method for producing alcohol compound
CN105175365A (en) Method for efficiently synthesizing beta-benzyl butyrolactone having specific configuration
KR101818836B1 (en) SYNTHESIZING METHOD OF α-ARYL-β-HYDROXY WEINREB AMIDES
KR101102094B1 (en) Method of preparing chiral ß-sustituted ?-lactol, ?-lactone and chiral ß-sustituted ?-lactol, ?-lactone prepared by thereof
JP4674393B2 (en) Process for producing optically active fluorine-containing β-hydroxy ester
JP2002508345A (en) Asymmetric hydrogenation
US6998495B2 (en) Method for producing optically active 3,5-dihydroxycarboxylic acid derivative
JP3826425B2 (en) Method for producing optically active 2-nitro-1,3-diol derivative
JP4428086B2 (en) Method for producing 1-acetoxy-3- (3,4-methylenedioxyphenyl) propene derivative
KR102071898B1 (en) Method for preparing highly enantio-enriched gingerols
JP2010195737A (en) Method for producing optically active convolutamydine derivative
KR101465351B1 (en) METHOD FOR PREPARING CHIRAL β-HYDROXY THIOESTER BY CATALYTIC ENANTIOSELECTIVE ALDOL REACTION AND CHIRAL β-HYDROXY THIOESTER SYNTHESIZED BY THE METHOD
JP2009184945A (en) Method for purifying optically active 1-(2-trifluoromethylphenyl)ethanol
JP2003128629A (en) Method for producing optically active 6-halogeno-3,5- dihydroxyhexanoic acid derivative
KR100462473B1 (en) Method for the preparation of chiral hydroxy esters by enzyme-metal multi-catalysis
JP4311241B2 (en) Process for producing 1-alkylcarbonyloxy-3-substituted phenyl-propene compound
KR20120120683A (en) Method for preparing chiral -nitrothioester by catalytic enantioselective michael addition reactions
SU1532556A1 (en) Method of producing e-1-methyl-1-methoxycarbonyl-2-ethoxycarbonylcyclopropane

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20150710

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20160705

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee